Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Pharma stocks under...

    Pharma stocks under pressure, fall up to 5 percent

    Written by Ruby Khatun Khatun Published On 2017-08-07T09:16:42+05:30  |  Updated On 7 Aug 2017 9:16 AM IST
    Pharma stocks under pressure, fall up to 5 percent

    New Delhi: Pharma stocks were under selling pressure, falling up to 5 per cent, led by Biocon and Dr Reddy's Lab.


    Shares of Morepen Laboratories fell by 4.79 per cent, Biocon slipped 4.78 per cent, Dr Reddys Lab dipped 3.76 per cent and Sun Pharma Advanced Research Company (3.48 per cent).


    Also, RPG Life Sciences fell by 3.15 per cent, Jubilant Life Sciences (2.25 per cent), Aurobindo Pharma (2.18 per cent), Glenmark Pharmaceuticals (1.92 per cent) and Lupin (0.24 per cent).


    The BSE healthcare index fell by 0.94 per cent to settle at 13,877.80. "Pharma sector continued to face US regulatory and pricing pressure which refrained investors to give focus even at the low valuation," said Vinod Nair, Head of Research, Geojit Financial Services Ltd.


    Also there was reports in the media that Biocon has got Form 483 with 10 observations from USFDA for Bangalore plant. Reacting to this, shares of the company plunged 9.13 per cent to Rs 341 in intra-day trading session on BSE. The 30-share key BSE index started on a bearish note, but late buying helped it settle up 87.53 points, or 0.27 per cent, at 32,325.41.

    Aurobindo PharmaBioconDr Reddy's LaboratoriesfallGlenmarkJubilant Life SciencesLupinMorepen LaboratoriespharmaPharma StockspressureSharesstocksSun PharmaVinod Nair
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok